From: DNA methylation: potential biomarker in Hepatocellular Carcinoma
Gene | HCC patients (n) | Clinicopathological correlation | Validation method | Publication | Year |
---|---|---|---|---|---|
p16 | 28 | Tumor stage | MSP | Yu et al. [56] | 2003 |
 | 18 | Tumor stage | MSP | Shim et al. [59] | 2003 |
 | 20 | Tumor differentiation | MSP | Qin et al. [66] | 2004 |
 | 50 | Age, gender, virus infection (HBV/HCV) | MSP | Li et al. [62] | 2004 |
 | 44 | HBV infection | MSP | Jicai et al. [63] | 2006 |
 | 60 | Age, tumor stage, vascular invasion, virus infection (HBV/HCV) | MSP | Katoh et al. [61] | 2006 |
 | 58 | Tumor stage | MSP | Su et al. [60] | 2007 |
 | 23 | HBV infection (HBx) | MSP | Zhu et al. [65] | 2007 |
 | 265 | Disease free survival | MSP | Ko et al. [70] | 2008 |
 | 118 | Gender | Methylscreen | Wang et al. [119] | 2012 |
SOCS1 | 50 | Liver cirrhosis | MSP | Okochi et al. [77] | 2003 |
 | 51 | HCV infection | MSP | Yang et al. [54] | 2003 |
 | 284 | Age, tumor size, virus infection (HBV/HCV) | MSP | Ko et al. [73] | 2008 |
 | 77 | HCV infection | COBRA | Nishida et al. [76] | 2008 |
 | 46 | Liver cirrhosis, tumor size | MSP | Chu et al. [75] | 2010 |
 | 46 | Tumor stage | MethyLight | Um et al. [72] | 2011 |
 | 29 | Chemotherapy treatment | MSP | Saelee et al. [120] | 2012 |
 | 116 | Age and gender | Methylscreen | Zhang et al. [74] | 2013 |
GSTP1 | 60 | Overall survival | MSP | Lee et al. [55] | 2003 |
 | 83 | Alcohol consumption, gender | MSP | Zhang et al. [82] | 2005 |
 | 60 | Gender, viral infection (HBV/HCV) | MSP | Katoh et al. [61] | 2006 |
 | 58 | HBV infection, tumor stage | MSP | Su et al. [60] | 2007 |
 | 77 | HCV infection | COBRA | Nishida et al. [76] | 2008 |
 | 166 | HBV infection | Pyrosequencing | Lambert et al. [81] | 2011 |
CDH1 | 60 | Overall survival | MSP | Lee et al. [55] | 2003 |
 | 32 | Vascular invasion, recurrence | MSP | Ghee [91] | 2005 |